| 1 | [SID103197283] | Active | | | Reduction of pneumolysin production in Streptococcus pneumoniae NMU112 lysates at 5 ug/mL after 12 hrs by Western blot relative to control [AID326069, Type: Literature] | |   View X | Row No. | 1 | | Structure | 
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Reduction of pneumolysin production in Streptococcus pneumoniae NMU112 lysates at 5 ug/mL after 12 hrs by Western blot relative to control | | AID | 326069 | | BioAssay type | Literature | | Target | | | PubMed | 17353244 | | Data Table | |
|
| 2 | [SID103197283] | Active | | | Inhibition of pneumococcal surface protein A production in Streptococcus pneumoniae NMU112 lysates at 5 ug/mL after 12 hrs by Western blot relative to control [AID326071, Type: Literature] | | View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Inhibition of pneumococcal surface protein A production in Streptococcus pneumoniae NMU112 lysates at 5 ug/mL after 12 hrs by Western blot relative to control | | AID | 326071 | | BioAssay type | Literature | | Target | | | PubMed | 17353244 | | Data Table | |
|
| 3 | [SID103197283] | Active | | | Antimicrobial activity against Streptococcus pneumoniae NMU112 infected in po dosed CBA/J mouse assessed as delaying in development of bacteremia relative to roxithromycin [AID326091, Type: Literature] | | View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against Streptococcus pneumoniae NMU112 infected in po dosed CBA/J mouse assessed as delaying in development of bacteremia relative to roxithromycin | | AID | 326091 | | BioAssay type | Literature | | Target | | | PubMed | 17353244 | | Data Table | |
|
| 4 | [SID103197283] | Active | | | Ratio of MIC for Campylobacter jejuni 001B-22 carrying A2075G mutation in 23S rRNA to MIC for Campylobacter jejuni 001B-22 cmeB::kanamycin-resistant mutant [AID369664, Type: Literature] | | View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Ratio of MIC for Campylobacter jejuni 001B-22 carrying A2075G mutation in 23S rRNA to MIC for Campylobacter jejuni 001B-22 cmeB::kanamycin-resistant mutant | | AID | 369664 | | BioAssay type | Literature | | Target | | | PubMed | 17606685 | | Data Table | |
|
| 5 | [SID103197283] | Active | | | Antimycobacterial activity against Mycobacterium ulcerans isolate CU001 infected in BALB/c mouse left hind foot-pad assessed as incidence of bacterial infection at 100 mg/kg, po administered for 5 days per week measured after 8 weeks [AID416846, Type: Literature] | | View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimycobacterial activity against Mycobacterium ulcerans isolate CU001 infected in BALB/c mouse left hind foot-pad assessed as incidence of bacterial infection at 100 mg/kg, po administered for 5 days per week measured after 8 weeks | | AID | 416846 | | BioAssay type | Literature | | Target | | | PubMed | 17664316 | | Data Table | |
|
| 6 | [SID103197283] | Active | | | Antibacterial activity against extracellular Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease at 0.01 to 10 ug/ml after 3 hrs [AID425596, Type: Literature] | | View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antibacterial activity against extracellular Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease at 0.01 to 10 ug/ml after 3 hrs | | AID | 425596 | | BioAssay type | Literature | | Target | | | PubMed | 18070962 | | Data Table | |
|
| 7 | [SID103197283] | Active | | | Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method [AID426375, Type: Literature] | | View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method | | AID | 426375 | | BioAssay type | Literature | | Target | | | PubMed | 19560350 | | Data Table | |
|
| 8 | [SID103197283] | Active | | | Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae 07H252 by broth microdilution method [AID426376, Type: Literature] | | View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae 07H252 by broth microdilution method | | AID | 426376 | | BioAssay type | Literature | | Target | | | PubMed | 19560350 | | Data Table | |
|
| 9 | [SID103197283] | Active | | | Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes 07U084 by broth microdilution method [AID426379, Type: Literature] | | View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes 07U084 by broth microdilution method | | AID | 426379 | | BioAssay type | Literature | | Target | | | PubMed | 19560350 | | Data Table | |
|
| 10 | [SID103197283] | Active | | | Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes 07U086 by broth microdilution method [AID426380, Type: Literature] | | View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes 07U086 by broth microdilution method | | AID | 426380 | | BioAssay type | Literature | | Target | | | PubMed | 19560350 | | Data Table | |
|
| 11 | [SID103197283] | Active | | | Fraction absorbed in human [AID444055, Type: Literature] | | View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Fraction absorbed in human | | AID | 444055 | | BioAssay type | Literature | | Target | | | PubMed | 20070106 | | Data Table | |
|
| 12 | [SID103197283] | Active | | | Fraction escaping gut-wall elimination in human [AID444056, Type: Literature] | | View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Fraction escaping gut-wall elimination in human | | AID | 444056 | | BioAssay type | Literature | | Target | | | PubMed | 20070106 | | Data Table | |
|
| 13 | [SID103197283] | Active | | | Fraction escaping hepatic elimination in human [AID444057, Type: Literature] | | View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Fraction escaping hepatic elimination in human | | AID | 444057 | | BioAssay type | Literature | | Target | | | PubMed | 20070106 | | Data Table | |
|
| 14 | [SID103197283] | Active | | | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in total cell count in bronchoalveolar lavage fluid at 40 mg/kg, po bid for 3 days [AID496385, Type: Literature] | | View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in total cell count in bronchoalveolar lavage fluid at 40 mg/kg, po bid for 3 days | | AID | 496385 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 15 | [SID103197283] | Active | | | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in total cell count in bronchoalveolar lavage fluid at 100 mg/kg, po bid for 3 days [AID496386, Type: Literature] | | View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in total cell count in bronchoalveolar lavage fluid at 100 mg/kg, po bid for 3 days | | AID | 496386 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 16 | [SID103197283] | Active | | | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in neutrophil count in bronchoalveolar lavage fluid at 40 mg/kg, po bid for 3 days [AID496387, Type: Literature] | | View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in neutrophil count in bronchoalveolar lavage fluid at 40 mg/kg, po bid for 3 days | | AID | 496387 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 17 | [SID103197283] | Active | | | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in neutrophil count in bronchoalveolar lavage fluid at 100 mg/kg, po bid for 3 days relative to control [AID496388, Type: Literature] | | View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in neutrophil count in bronchoalveolar lavage fluid at 100 mg/kg, po bid for 3 days relative to control | | AID | 496388 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 18 | [SID103197283] | Active | | | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in IL1-beta level in bronchoalveolar lavage fluid at 100 mg/kg, po bid for 3 days relative to control [AID496390, Type: Literature] | | View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in IL1-beta level in bronchoalveolar lavage fluid at 100 mg/kg, po bid for 3 days relative to control | | AID | 496390 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 19 | [SID103197283] | Active | | | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in MIP-2 level in bronchoalveolar lavage fluid at 40 mg/kg, po bid for 3 days relative to control [AID496391, Type: Literature] | | View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in MIP-2 level in bronchoalveolar lavage fluid at 40 mg/kg, po bid for 3 days relative to control | | AID | 496391 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 20 | [SID103197283] | Active | | | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in MIP-2 level in bronchoalveolar lavage fluid at 100 mg/kg, po bid for 3 days relative to control [AID496392, Type: Literature] | | View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in MIP-2 level in bronchoalveolar lavage fluid at 100 mg/kg, po bid for 3 days relative to control | | AID | 496392 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 21 | [SID103197283] | Active | | | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae infected in mouse ddY assessed as inflammatory changes in lung at 40 mg/kg, po bid for 3 days relative to control [AID496393, Type: Literature] | | View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae infected in mouse ddY assessed as inflammatory changes in lung at 40 mg/kg, po bid for 3 days relative to control | | AID | 496393 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 22 | [SID103197283] | Active | | | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae infected in mouse ddY assessed as inflammatory changes in lung at 100 mg/kg, po bid for 3 days relative to control [AID496394, Type: Literature] | | View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae infected in mouse ddY assessed as inflammatory changes in lung at 100 mg/kg, po bid for 3 days relative to control | | AID | 496394 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 23 | [SID103197283] | Active | | | Antibacterial activity against macrolide-resistant Haemophilus influenzae 4437 infected in NCI-H292 cells assessed as decrease in viable bacterial count at 64 ug/ml by 3-h invasion assay [AID496395, Type: Literature] | | View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antibacterial activity against macrolide-resistant Haemophilus influenzae 4437 infected in NCI-H292 cells assessed as decrease in viable bacterial count at 64 ug/ml by 3-h invasion assay | | AID | 496395 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 24 | [SID103197283] | Active | | | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in IL1-beta level in bronchoalveolar lavage fluid at 40 mg/kg, po bid for 3 days relative to control [AID496511, Type: Literature] | | View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antiinflammatory activity against nontypeable beta-lactamase-negative ampicillin-resistant Haemophilus influenzae 4437 infected in mouse ddY assessed as decrease in IL1-beta level in bronchoalveolar lavage fluid at 40 mg/kg, po bid for 3 days relative to control | | AID | 496511 | | BioAssay type | Literature | | Target | | | PubMed | 19949056 | | Data Table | |
|
| 25 | [SID103197283] | Active | | | Antibacterial activity against Helicobacter pylori Hp 26695 [AID502779, Type: Literature] | | View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antibacterial activity against Helicobacter pylori Hp 26695 | | AID | 502779 | | BioAssay type | Literature | | Target | | | PubMed | 20705463 | | Data Table | |
|
| 26 | [SID103197283] | Active | | | Antibacterial activity against multidrug-resistant Helicobacter pylori v1354 [AID502781, Type: Literature] | | View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antibacterial activity against multidrug-resistant Helicobacter pylori v1354 | | AID | 502781 | | BioAssay type | Literature | | Target | | | PubMed | 20705463 | | Data Table | |
|
| 27 | [SID103197283] | Active | | | Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bactericidal at 8 times MIC in 24 hrs by time kill study [AID524550, Type: Literature] | | View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bactericidal at 8 times MIC in 24 hrs by time kill study | | AID | 524550 | | BioAssay type | Literature | | Target | | | PubMed | 20176910 | | Data Table | |
|
| 28 | [SID103197283] | Active | | | Antimicrobial activity against Mycobacterium abscessus 390S infected in human monocyte-derived macrophage assessed as reduction in viable bacteria count at 10 times MIC by trypan blue exclusion assay [AID525097, Type: Literature] | | View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against Mycobacterium abscessus 390S infected in human monocyte-derived macrophage assessed as reduction in viable bacteria count at 10 times MIC by trypan blue exclusion assay | | AID | 525097 | | BioAssay type | Literature | | Target | | | PubMed | 18378709 | | Data Table | |
|
| 29 | [SID103197283] | Active | | | Bacteriostatic activity against Mycobacterium abscessus 390S infected in human monocyte-derived macrophage assessed as inhibition of planktonic cell growth at 4 ug/ml treated 24 hrs postinfection [AID525098, Type: Literature] | | View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Bacteriostatic activity against Mycobacterium abscessus 390S infected in human monocyte-derived macrophage assessed as inhibition of planktonic cell growth at 4 ug/ml treated 24 hrs postinfection | | AID | 525098 | | BioAssay type | Literature | | Target | | | PubMed | 18378709 | | Data Table | |
|
| 30 | [SID103197283] | Active | | | Bacteriostatic activity against Mycobacterium abscessus 390R infected in human monocyte-derived macrophage assessed as inhibition of planktonic cell growth at 4 ug/ml treated 24 hrs postinfection [AID525099, Type: Literature] | | View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Bacteriostatic activity against Mycobacterium abscessus 390R infected in human monocyte-derived macrophage assessed as inhibition of planktonic cell growth at 4 ug/ml treated 24 hrs postinfection | | AID | 525099 | | BioAssay type | Literature | | Target | | | PubMed | 18378709 | | Data Table | |
|
| 31 | [SID103197283] | Active | | | Bacteriostatic activity against Mycobacterium abscessus 390V infected in human monocyte-derived macrophage assessed as inhibition of planktonic cell growth at 4 ug/ml treated 24 hrs postinfection [AID525100, Type: Literature] | | View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Bacteriostatic activity against Mycobacterium abscessus 390V infected in human monocyte-derived macrophage assessed as inhibition of planktonic cell growth at 4 ug/ml treated 24 hrs postinfection | | AID | 525100 | | BioAssay type | Literature | | Target | | | PubMed | 18378709 | | Data Table | |
|
| 32 | [SID103197283] | Active | | | Fraction unbound in human after iv administration [AID540211, Type: Literature] | | View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Fraction unbound in human after iv administration | | AID | 540211 | | BioAssay type | Literature | | Target | | | PubMed | 18426954 | | Data Table | |
|
| 33 | [SID103197283] | Active | | | Antimicrobial activity against in Escherichia coli ATCC 25922 in presence of NAB741 [AID545918, Type: Literature] | | View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against in Escherichia coli ATCC 25922 in presence of NAB741 | | AID | 545918 | | BioAssay type | Literature | | Target | | | PubMed | 20479195 | | Data Table | |
|
| 34 | [SID103197283] | Active | | | Antimicrobial activity against in Escherichia coli IH3080 in presence of NAB741 [AID545922, Type: Literature] | | View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against in Escherichia coli IH3080 in presence of NAB741 | | AID | 545922 | | BioAssay type | Literature | | Target | | | PubMed | 20479195 | | Data Table | |
|
| 35 | [SID103197283] | Active | | | Antimicrobial activity against in Klebsiella pneumoniae ATCC 13883 in presence of NAB741 [AID545926, Type: Literature] | | View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against in Klebsiella pneumoniae ATCC 13883 in presence of NAB741 | | AID | 545926 | | BioAssay type | Literature | | Target | | | PubMed | 20479195 | | Data Table | |
|
| 36 | [SID103197283] | Active | | | Antimicrobial activity against in Enterobacter cloacae ATCC 23355 in presence of NAB741 [AID545930, Type: Literature] | | View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against in Enterobacter cloacae ATCC 23355 in presence of NAB741 | | AID | 545930 | | BioAssay type | Literature | | Target | | | PubMed | 20479195 | | Data Table | |
|
| 37 | [SID103197283] | Active | | | Antimicrobial activity against in Acinetobacter baumannii ATCC 19606 in presence of NAB741 [AID545934, Type: Literature] | | View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antimicrobial activity against in Acinetobacter baumannii ATCC 19606 in presence of NAB741 | | AID | 545934 | | BioAssay type | Literature | | Target | | | PubMed | 20479195 | | Data Table | |
|
| 38 | [SID103197283] | Active | | | Ratio of MIC for Acinetobacter baumannii ATCC 19606 to MIC for Acinetobacter baumannii ATCC 19606 in presence of 4 ug/ml of NAB741 [AID545939, Type: Literature] | | View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Ratio of MIC for Acinetobacter baumannii ATCC 19606 to MIC for Acinetobacter baumannii ATCC 19606 in presence of 4 ug/ml of NAB741 | | AID | 545939 | | BioAssay type | Literature | | Target | | | PubMed | 20479195 | | Data Table | |
|
| 39 | [SID103197283] | Active | | | Antibacterial activity against Escherichia coli by CLSI method in presence of 2 mg/L tachyplesin 3 [AID553820, Type: Literature] | | View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antibacterial activity against Escherichia coli by CLSI method in presence of 2 mg/L tachyplesin 3 | | AID | 553820 | | BioAssay type | Literature | | Target | | | PubMed | 18779356 | | Data Table | |
|
| 40 | [SID103197283] | Active | | | Induction of erm(C) expression in Escherichia coli JM109 harboring Staphylococcus aureus erm(C)-containing pERMZalpha reporter plasmid at 8 mg/ml after 36 hrs at 37 degC by disc-based beta-galactosidase reporter gene assay [AID518967, Type: Literature] | | View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Induction of erm(C) expression in Escherichia coli JM109 harboring Staphylococcus aureus erm(C)-containing pERMZalpha reporter plasmid at 8 mg/ml after 36 hrs at 37 degC by disc-based beta-galactosidase reporter gene assay | | AID | 518967 | | BioAssay type | Literature | | Target | | | PubMed | 18086834 | | Data Table | |
|
| 41 | [SID103197283] | Active | | | Antibacterial activity against Escherichia coli ATCC 25992 by Etest method in presence of NAB7061 [AID571200, Type: Literature] | | View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antibacterial activity against Escherichia coli ATCC 25992 by Etest method in presence of NAB7061 | | AID | 571200 | | BioAssay type | Literature | | Target | | | PubMed | 18591267 | | Data Table | |
|
| 42 | [SID103197283] | Active | | | Antibacterial activity against Acinetobacter baumannii F264 by Etest method in presence of NAB739 [AID571211, Type: Literature] | | View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antibacterial activity against Acinetobacter baumannii F264 by Etest method in presence of NAB739 | | AID | 571211 | | BioAssay type | Literature | | Target | | | PubMed | 18591267 | | Data Table | |
|
| 43 | [SID103197283] | Active | | | Antibacterial activity against Acinetobacter baumannii ATCC 19606 by Etest method in presence of NAB739 [AID571392, Type: Literature] | | View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Antibacterial activity against Acinetobacter baumannii ATCC 19606 by Etest method in presence of NAB739 | | AID | 571392 | | BioAssay type | Literature | | Target | | | PubMed | 18591267 | | Data Table | |
|
| 44 | [SID103197283] | Active | | | Ratio of the MIC for Acinetobacter baumannii in the absence of NAB7071 to MIC for Acinetobacter baumannii in the presence of 4 ug/ml of NAB7071 [AID571661, Type: Literature] | | View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Ratio of the MIC for Acinetobacter baumannii in the absence of NAB7071 to MIC for Acinetobacter baumannii in the presence of 4 ug/ml of NAB7071 | | AID | 571661 | | BioAssay type | Literature | | Target | | | PubMed | 18591267 | | Data Table | |
|
| 45 | [SID103197283] | Active | | | Ratio of the MIC for Serratia marcescens ATCC 8100 in the absence of NAB7072 to MIC for Serratia marcescens ATCC 8100 in the presence of 4 ug/ml of NAB7072 [AID571662, Type: Literature] | | View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Ratio of the MIC for Serratia marcescens ATCC 8100 in the absence of NAB7072 to MIC for Serratia marcescens ATCC 8100 in the presence of 4 ug/ml of NAB7072 | | AID | 571662 | | BioAssay type | Literature | | Target | | | PubMed | 18591267 | | Data Table | |
|
| 46 | [SID103197283] | Active | | | Ratio of the MIC for Proteus mirabilis ATCC 29906 in the absence of NAB7073 to MIC for Proteus mirabilis ATCC 29906 in the presence of 4 ug/ml of NAB7073 [AID571663, Type: Literature] | | View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Ratio of the MIC for Proteus mirabilis ATCC 29906 in the absence of NAB7073 to MIC for Proteus mirabilis ATCC 29906 in the presence of 4 ug/ml of NAB7073 | | AID | 571663 | | BioAssay type | Literature | | Target | | | PubMed | 18591267 | | Data Table | |
|
| 47 | [SID103197283] | Active | | | Ratio of the MIC for Proteus vulgaris ATCC 13315 in the absence of NAB7074 to MIC for Proteus vulgaris ATCC 13315 in the presence of 4 ug/ml of NAB7074 [AID571664, Type: Literature] | | View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Ratio of the MIC for Proteus vulgaris ATCC 13315 in the absence of NAB7074 to MIC for Proteus vulgaris ATCC 13315 in the presence of 4 ug/ml of NAB7074 | | AID | 571664 | | BioAssay type | Literature | | Target | | | PubMed | 18591267 | | Data Table | |
|
| 48 | [SID103197283] | Active | | | Ratio of the MIC for Pseudomonas aeruginosa ATCC 27853 in the absence of NAB7075 to MIC for Pseudomonas aeruginosa ATCC 27853 in the presence of 4 ug/ml of NAB7075 [AID571665, Type: Literature] | | View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Ratio of the MIC for Pseudomonas aeruginosa ATCC 27853 in the absence of NAB7075 to MIC for Pseudomonas aeruginosa ATCC 27853 in the presence of 4 ug/ml of NAB7075 | | AID | 571665 | | BioAssay type | Literature | | Target | | | PubMed | 18591267 | | Data Table | |
|
| 49 | [SID103197283] | Active | | | Ratio of MIC for Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene to MIC for Escherichia coli K-12 3-AG300 [AID571927, Type: Literature] | | View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Ratio of MIC for Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene to MIC for Escherichia coli K-12 3-AG300 | | AID | 571927 | | BioAssay type | Literature | | Target | | | PubMed | 18936189 | | Data Table | |
|
| 50 | [SID103197283] | Active | | | Ratio of MIC for Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB mutant gene to MIC for Escherichia coli K-12 3-AG300 [AID571928, Type: Literature] | | View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103197283 | | CID | 54688 | | Outcome | Active | | BioAssay | Ratio of MIC for Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB mutant gene to MIC for Escherichia coli K-12 3-AG300 | | AID | 571928 | | BioAssay type | Literature | | Target | | | PubMed | 18936189 | | Data Table | |
|
Chemical Probe 
Active 
Inactive 
Inconclusive 
Unspecified 
